Number and percentage of patients aged 15–24 who died in the 2 years following diagnosis, by 3-month period, year and trial status
| Year | Quarter | In trial | Not in trial | p Value | ||||||
| Number of patients at start of period | Number of deaths | % Died | 95% CI | Number of patients at start of period | Number of deaths | % Died | 95% CI | |||
| First | 239 | 6 | 2.5 | 1.2 to 5.4 | 264 | 21 | 8.0 | 5.3 to 11.9 | 0.007 | |
| Second | 233 | 4 | 1.7 | 0.7 to 4.3 | 243 | 5 | 2.1 | 0.9 to 4.7 | 0.785 | |
| Third | 229 | 5 | 2.2 | 0.9 to 5.0 | 238 | 11 | 4.6 | 2.6 to 8.1 | 0.148 | |
| Fourth | 224 | 7 | 3.1 | 1.5 to 6.3 | 227 | 11 | 4.8 | 2.7 to 8.5 | 0.351 | |
| First | – | 239 | 22 | 9.2 | 6.2 to 13.5 | 264 | 48 | 18.2 | 14.0 to 23.3 | 0.004 |
| Fifth | 217 | 2 | 0.9 | 0.3 to 3.3 | 216 | 11 | 5.1 | 2.9 to 8.9 | 0.011 | |
| Sixth | 215 | 4 | 1.9 | 0.7 to 4.7 | 205 | 10 | 4.9 | 2.7 to 8.7 | 0.0851 | |
| Seventh | 211 | 3 | 1.4 | 0.5 to 4.1 | 195 | 8 | 4.1 | 2.1 to 7.9 | 0.0965 | |
| Eighth | 208 | 4 | 1.9 | 0.8 to 4.8 | 187 | 9 | 4.8 | 2.6 to 8.9 | 0.108 | |
| Second | – | 217 | 13 | 6.0 | 3.5 to 10.0 | 216 | 38 | 17.6 | 13.1 to 23.2 | <0.001 |
| First and second | – | 239 | 35 | 14.6 | 10.7 to 19.7 | 264 | 86 | 32.6 | 27.2 to 38.4 | <0.001 |